What is King Pharmaceuticals's total operating expenses?

King Pharmaceuticals (KG) reported total operating expenses of $4.35M in Q3 2025.

What does total operating expenses mean?

The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

King Pharmaceuticals KG Total Operating Expenses

Discontinued — last reported Q3 '25

Total Operating Expenses at other companies

Silvercrest Asset Management GroupSAMG

$30.14M+13.5%

Tiptree Inc.TIPT

——

Segments

By segment

See full

Legacy Reinsurance$2.71M—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: King Pharmaceuticals’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's total operating expenses?: King Pharmaceuticals (KG) reported total operating expenses of $4.35M in Q3 2025.
What does total operating expenses mean?: The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.